Granström G, Wretlind B, Salenstedt C R, Granström M
Department of Infectious Diseases, Danderyd Hospital, Sweden.
J Clin Microbiol. 1988 Sep;26(9):1818-23. doi: 10.1128/jcm.26.9.1818-1823.1988.
An enzyme-linked immunosorbent assay (ELISA) for the immunoglobulin G (IgG), IgM, and IgA response to Bordetella pertussis filamentous hemagglutinin (FHA) and pertussis toxin (PT) and a neutralization test (NT) in a microplate tissue culture assay for neutralizing antibodies to PT were evaluated in paired sera from 90 patients with culture-confirmed pertussis. Eighty patients were children (age, less than 15 years), and 6 of 80 children had been immunized with three doses of diphtheria-tetanus-pertussis vaccine as infants. A significant titer rise (greater than or equal to twofold), determined by ELISA, of IgG, IgM, and IgA to FHA was recorded in 75 (83%), 28 (31%), and 47 (52%) of the patients, respectively. A significant titer rise to PT in IgG was found in 83 (92%), IgM in 29 (32%), and IgA in 44 (49%) of the patients. A significant titer rise to FHA or PT in IgG was found in 88 (98%) of the patients, in combination with a significant rise in the titer of IgA to FHA. These data were obtained in a single serum dilution of 1:500. Titrations performed later showed that the titer rise to FHA in IgG was a mean of 6.5-fold, which was significantly lower than the mean 67.0-fold rise in IgG to PT (P less than 0.001). The mean titer of IgG to FHA in convalescent-phase serum was 270, which was also significantly lower than the mean PT titer of 2,943 (P less than 0.001). A significant rise (greater than or equal to fourfold) in PT titer by NT was found in 58 of 83 (70%) of the patients. The NT was significantly less sensitive than the ELISA for the determination of the IgG titer to PT ( P< 0.001). Results showed that a 100% (90 of 90) sensitivity in terms of titer rises was achieved in the serologic diagnosis of pertussis by ELISA in a single-point determination of the IgG and IgA responses to FHA and of the IgG response to PT.
对90例培养确诊百日咳患者的配对血清,评估了一种用于检测针对百日咳博德特氏菌丝状血凝素(FHA)和百日咳毒素(PT)的免疫球蛋白G(IgG)、IgM和IgA反应的酶联免疫吸附测定(ELISA),以及一种用于检测针对PT的中和抗体的微孔板组织培养中和试验(NT)。80例患者为儿童(年龄小于15岁),其中80名儿童中有6名婴儿期已接种三剂白喉-破伤风-百日咳疫苗。通过ELISA测定,分别有75例(83%)、28例(31%)和47例(52%)患者的IgG、IgM和IgA针对FHA出现显著滴度升高(大于或等于两倍)。83例(92%)患者的IgG针对PT出现显著滴度升高,29例(32%)患者的IgM以及44例(49%)患者的IgA针对PT出现显著滴度升高。88例(98%)患者的IgG针对FHA或PT出现显著滴度升高,同时IgA针对FHA的滴度也显著升高。这些数据是在1:500的单一血清稀释度下获得的。随后进行的滴定显示,IgG针对FHA的滴度升高平均为6.5倍,显著低于IgG针对PT的平均67.0倍升高(P<0.001)。恢复期血清中IgG针对FHA的平均滴度为270,也显著低于PT的平均滴度2943(P<0.001)。83例患者中有58例(70%)通过NT检测到PT滴度显著升高(大于或等于四倍)。在检测针对PT的IgG滴度方面,NT的敏感性显著低于ELISA(P<0.001)。结果显示,通过ELISA对IgG和IgA针对FHA的反应以及IgG针对PT的反应进行单点测定,在百日咳的血清学诊断中,就滴度升高而言,敏感性达到了100%(90例中的90例)。